Kardigan

Kardigan

Heart health company aiming to make cardiovascular disease preventable and curable with innovative drug development.

HQ location
South San Francisco, United States
Launch date
Employees
Enterprise value
$1.2—1.8b
Recent deals
  • Edit
More about Kardigan
Made with AI
Edit

Kardigan is a heart health company dedicated to transforming the landscape of cardiovascular medicine. With a leadership team of seasoned biopharma veterans, the company focuses on making cardiovascular disease preventable and curable. Kardigan operates in the biotechnology sector, targeting patients with cardiovascular conditions. The business model revolves around the discovery and development of multiple important medicines at an unprecedented pace, leveraging their deep expertise in cardiovascular drug development. Kardigan's revenue is generated through the commercialization of these medicines, aiming to address the global challenge of cardiovascular disease, which remains a leading cause of death worldwide. The company is driven by a commitment to modernize the discovery and development process, bringing a high level of focus and passion to their mission.

Keywords: cardiovascular, heart health, drug development, biotechnology, biopharma, medicine, disease prevention, curable, leadership, expertise

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Kardigan

Edit
Prolaio
ACQUISITION by Kardigan Mar 2025